Laser treatment then focused radiation for new brain gliomas
Part of Brain & nervous system, Cancer clinical trials.
This trial studies a two-step treatment for newly diagnosed high-grade glioma: first laser treatment (LITT) to target the tumor, followed by a shorter, more focused course of radiation. It may help shrink or control the tumor while limiting treatment time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older) with imaging that suggests a primary high-grade brain glioma
- You have a brain MRI with contrast showing a tumor area within the last 60 days, and neurosurgery says you could receive LITT based on that MRI
- A recent medical check-up and neurological exam must be done within 30 days before starting
- Your overall function must be at least moderate (Karnofsky score 50% or higher) within 30 days
- You must be able to have an MRI scan (no MRI limits like certain implanted devices or severe claustrophobia)
- If pregnancy is possible, you must agree to effective birth control during treatment and for 6 months after, and women of child-bearing potential need a negative pregnancy test within 28 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, shorter course of radiation therapy (called hypofractionation) for people with glioblastoma that has come back. It is for patients who have already had radiation and are doing well enough to consider another round.
This trial tests a minimally invasive laser procedure combined with a new immunotherapy drug (cemiplimab) to treat glioblastoma that has returned after initial treatment. The laser heats and destroys the tumor while the immunotherapy helps your immune system fight remaining cancer cells.
This trial tests a shorter, more intense course of radiation therapy (hypofractionated radiotherapy) for people with newly diagnosed glioblastoma who have had surgery. The goal is to see if this approach is safe and works well for treating the tumor.
This study tests a light-activated therapy (radiodynamic therapy) using a special medicine to help treat a brain tumor that has come back after prior treatment. It may be offered after doctors decide you need further radiation for your recurrence.
This trial combines laser heat therapy (LITT) with the chemotherapy drug lomustine (CCNU) for people whose glioblastoma has returned. It aims to see if the combination is safe and effective.
This trial tests a new type of targeted radiation therapy for people with high-grade glioma (grade 3 or 4) that has not progressed after standard treatment. The therapy uses a radioactive substance attached to a protein that targets tumor cells, aiming to deliver radiation directly to the cancer.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.